Wan-Ju Annabelle Lee

Dr. Wan-Ju Annabelle Lee

National Cheng Kung University, Tainan City, Taiwan
+1
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in BioDrugs
Verified
Journal Article
Closed access
PDF file
Wan-Ju Annabelle LeeWan-Ju Annabelle Lee
Wan-Ju Annabelle Lee
SSShih-Chieh Shao
Shih-Chieh Shao
TLTzu-Chi Liao
Tzu-Chi Liao
SLSwu-Jane Lin
Swu-Jane Lin
CLChi-Chun Lai
Chi-Chun Lai
Edward Chia-Cheng LaiEdward Chia-Cheng Lai
Edward Chia-Cheng Lai

8 March 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
PLPeng-Hsuan Lee
Peng-Hsuan Lee
SSShih-Chieh Shao
Shih-Chieh Shao
Wan-Ju Annabelle LeeWan-Ju Annabelle Lee
Wan-Ju Annabelle Lee
Background: Orbital apex syndrome (OAS) is a rare ocular complication following by infection, inflammation, trauma, neoplasms, and vascularity. The epidemiological features of OAS remained limited, so this study aimed to present ophthalmic clinical features, determine the causes to evaluate the visual prognosis of orbital apex syndrome (OAS) patients in Taiwan. Methods: This was a retrospective study by reviewing the electronic medical records from National Cheng Kung University Hospital in Taiwan during 2017–2019. We included patients diagnosed with OAS to review their ocular symptoms and signs, visual acuity, ocular images, etiologies, treatment and visual prognosis. Results: Twenty cases (mean age: 65.55 ± 13.06; male: 75%) with the diagnosis of OAS were included in this study. All patients presented as unilateral involvement, but the initial ocular presentations and etiologies varied. For example, blurred vision was reported in 80% of these patients, and tumor-related compression (55%) and infection (15%) were the most frequent causes for the OAS. After the follow-up, we found 35% of patients' visions declined or worsened to the blindness, 15% of patients' visions remained stable, 20% of patients' visions had mild improvement, and 35% of patients' visions were not measured because of debilitating clinical condition. We identified three OAS patients with mortality (15%), and all of them were attributed to the underlying malignancies. Conclusion: The clinical magnifications and etiologies of OAS are heterogeneous in Taiwan. Our findings indicated the tumor-related compression is the most frequent causes of OAS in Taiwan, and it is also related to poor clinical outcomes.

30 August 2022 in QJM: An International Journal of Medicine
Verified
Journal Article
Open access
PDF file
Wan-Ju Annabelle LeeWan-Ju Annabelle Lee
Wan-Ju Annabelle Lee
As the coronavirus disease 2019 (COVID-19) pandemic continues to rise, the development of effective vaccines is of crucial importance to prevent further morbidity and mortality. At the same time, the adverse effects induced by vaccine has been disclosed. However, the information of neuro-ophthalmic manifestations after COVID-19 vaccine is scarce. We reported a case who had unilateral optic neuritis after COVID-19 vaccination.

8 September 2021 in BioDrugs
Verified
Journal Article
Closed access
PDF file
Wan-Ju Annabelle LeeWan-Ju Annabelle Lee
Wan-Ju Annabelle Lee
SSShih-Chieh Shao
Shih-Chieh Shao
TLTzu-Chi Liao
Tzu-Chi Liao
SLSwu-Jane Lin
Swu-Jane Lin
CLChi-Chun Lai
Chi-Chun Lai
Edward Chia-Cheng LaiEdward Chia-Cheng Lai
Edward Chia-Cheng Lai

30 August 2017 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
Wan-Ju Annabelle LeeWan-Ju Annabelle Lee
Wan-Ju Annabelle Lee
CCChing‐Lan Cheng
Ching‐Lan Cheng
CLCheng‐Han Lee
Cheng‐Han Lee
YYYea-Huei Kao Yang
Yea-Huei Kao Yang
SLSwu‐Jane Lin
Swu‐Jane Lin
CHCheng-Yang Hsieh
Cheng-Yang Hsieh

9 November 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
CLChing-Chih Liu
Ching-Chih Liu
Wan-Ju Annabelle LeeWan-Ju Annabelle Lee
Wan-Ju Annabelle Lee
Background: Neuro-ophthalmic manifestations after vaccines are rare, with optic neuritis (ON) being the most common presentation. Patients with vaccine-related ON are similar to those with idiopathic ON. The temporal relationship between vaccination against and the occurrence of ON is vital. Here, we report a case of bilateral ON after the administration of the ChAdOx1-S nCoV-19 SARS-CoV-2 vaccine. Case: A 49-year-old healthy Asian female presented with sudden onset of bilateral blurred vision within 2 days. She complained of photophobia and extraocular pain upon movement over 3 days. Upon examination, her best corrected visual acuity (BCVA) was 20/30 in the right eye and 20/200 in the left eye. Anterior segment findings were unremarkable, with normal intraocular pressure. Fundoscopic examination revealed bilateral disc edema with vessel engorgement. Visual field examination revealed profound visual field defect in both eyes. She denied any trauma, use of new medication or medical history. She had received the ChAdOx1 nCoV-19 SARS-CoV-2 vaccine 14 days prior. Under suspicion of vaccine-related optic neuritis, she was given intravenous methylprednisolone 1 gm/day for 3 days, shifting to oral prednisolone under gradual tapering for 2 weeks. Conclusions: Typically presenting with sudden-onset visual decline and extraocular pain during movement, acute ON is generally idiopathic. Bilateral ON is rare, but quick identification is important because it can potentially lead to permanent loss of vision if left untreated. Vaccination-induced ON is even rarer but not difficult to treat. However, such patients require further evaluation and long-term follow-up because they may be prone to other neurological disorders in the future.